IP Library Granted Patent US 7,169,603
Granted Patent B2
US 7,169,603 · App. 09/906,206 · Granted Jan 30, 2007

α-MSH related compounds and methods of use

Assignee: MGI Pharma Biologics, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,169,603
App. No.
09/906,206
Granted
Jan 30, 2007
Kind
B2
Abstract

The invention provides polypeptides containing α-MSH that can be used to treat diseases characterized by inflammation and/or autoimmunity. Also included in the invention are α-MSH analogs and nucleic acids encoding polypeptides containing α-MSH and α-MSH analogs optionally linked to heterologous sequences. Also included in the invention are methods of delivering α-MSH containing peptides, α-MSH analogs, an DNA encoding α-MSH and α-MSH analogs.

Claims (12)

1. A nucleic acid comprising a nucleotide sequence encoding a fusion polypeptide comprising the amino acid sequence MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPR EGKRSYSMEHFRWGKPV (SEQ ID NO:42).

2. A nucleic acid comprising a nucleotide sequence encoding a fusion polypeptide comprising the amino acid sequence MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPR EGKRSYSMEHFRWGKPVG (SEQ ID NO:47).

3. A nucleic acid comprising a nucleotide sequence encoding a fusion polypeptide comprising the amino acid sequence MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPR EGKRSYSMEHFRWGKPVGKK (SEQ ID NO:49).

4. A nucleic acid comprising a nucleotide sequence encoding a fusion polypeptide comprising the amino acid sequence MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPR EGKRSYSMEHFRWGKPVGKKR (SEQ ID NO:51).

5. An expression vector comprising the nucleic acid of claim 1 .

6. An expression vector comprising the nucleic acid of claim 2 .

7. An expression vector comprising the nucleic acid of claim 3 .

8. An expression vector comprising the nucleic acid of claim 4 .

9. A fusion polypeptide comprising the amino acid sequence MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPREGKRSY SMEHFRWGKPV (SEQ ID NO:42).

10. A fusion polypeptide comprising the amino acid sequence MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPREGKRSY SMEHFRWGKPVG (SEQ ID NO:47).

11. A fusion polypeptide comprising the amino acid sequence MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPREGKRSY SMEHFRWGKPVGKK (SEQ ID NO:49).

12. A fusion polypeptide comprising the amino acid sequence MPRSCCSRSGALLLALLLQASMEVRGWCLESSQCQDLTTESNLLECIRACKPREGKRSY SMEHFRWGKPVGKKR (SEQ ID NO:51).

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2009
From: EISAI CORPORATION OF NORTH AMERICA
To: EISAI INC.
Reel/Frame 023254/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 16, 2009
From: MGI PHARMA BIOLOGICS, INC.
To: EISAI CORPORATION OF NORTH AMERICA
Reel/Frame 022399/0001 →
CHANGE OF NAME Recorded Jul 21, 2006
From: ZYCOS INC.
To: MGI PHARMA BIOLOGICS, INC.
Reel/Frame 017971/0870 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2001
From: HEDLEY, MARY LYNNE; URBAN, ROBERT G.; AZIZ, NAZNEEN; CHEN, HONGMIN; ETEMAD-MOGHADAM, BIJAN; YIN, PENG
To: ZYCOS INC.
Reel/Frame 012234/0176 →
Continuity (6)
Provisional Application 6029831700 · Jun 14, 2001
Provisional Application 6025876400 · Dec 29, 2000
Provisional Application 6023838000 · Oct 6, 2000
Provisional Application 6022638200 · Aug 18, 2000
Provisional Application 6021838100 · Jul 14, 2000
Related Publication 20050239170A1 · Oct 27, 2005